Alvaro Curiel Garcia, PhD profile page

Dr. Álvaro Curiel García, is an associate research scientist at Columbia University Irving Medical Center, specializing in translational oncology and experimental therapeutics. His research focuses on pancreatic ductal adenocarcinoma and KRAS-driven cancers, with expertise in mouse models, patient-derived xenografts CRISPR/Cas9 tumor modeling and multi-omics integration. During his postdoctoral training Dr. Curiel García co-led the HIPPOCRATES Precision Medicine Trial, bridging preclinical discovery with patient treatment. He has collaborated with industry partners, contributing to the preclinical validation of renin-angiotensin system inhibitors that are now in clinical trials. Dr. Curiel García has been recognized with awards including the 40 Under 40 in Cancer Award and the Revson Senior Postdoctoral Fellowship. He is an active member of international consortia such as the NCI Computational Oncology Working Group and the Pancreatic Cancer Stromal Reprogramming Consortium.